Fluvoxamine for Treating COVID-19
Psychopharmacology and Psychiatry Updates - A podcast by Psychopharmacology Institute
![](https://is1-ssl.mzstatic.com/image/thumb/Podcasts113/v4/a9/69/49/a969490e-d250-e43b-39ed-9a8acc178615/mza_2271515149008366696.png/300x300bb-75.jpg)
Categories:
How effective is fluvoxamine in patients with COVID-19? A 2-week course of full-dose fluvoxamine decreased clinical deterioration in outpatients with symptomatic COVID-19 infection. Faculty: Jim Phelps, M.D. Hosts: Jessica Diaz, M.D.; Lorena Rodríguez, M.D. Learn more about our memberships here Earn 0.5 CMEs: Quick Take Vol. 30 Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19